Skip to main content
. 2008 Oct 20;117(3):392–399. doi: 10.1289/ehp.0800074

Table 2.

Pathology observed for > 10% of ToxRefDB chemicals in chronic/cancer rat and mouse studies.

Target organ Effect Percent observed
Rat
 Liver Hypertrophy 25
 Kidney Nephropathy 14
 Liver Vacuolization 12
 Thyroid Adenoma 11
 Thyroid Hyperplasia 11
Mouse
 Liver Hypertrophy 25
 Liver Adenoma 21
 Liver Necrosis 16
 Liver Adenoma/carcinoma combined 14
 Liver Pigmentation 14
 Liver Carcinoma 12